0000000001308462

AUTHOR

C. Schmid

showing 5 related works from this author

Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions

2007

Recent studies have provided evidence that the number and proliferation capacity of bone marrow-derived mesenchymal stem cells, as well as the number of osteoprogenitor cells are reduced in patients with fracture non-unions. For fracture non-unions that do not heal after appropriate surgical intervention, the question arises as to what extent systemic cellular dysfunctions should be considered as being pathogenetic factors. For this purpose, we have examined the hypothesis that the cell function of osteoblasts isolated from patients with fracture non-unions may differ from those of normal control individuals in an identical and controlled in vitro situation. We analyzed the osteoblast cell …

Pathologymedicine.medical_specialtyHistologyCell SurvivalPhysiologyEndocrinology Diabetes and MetabolismCellular differentiationDown-RegulationBone healingBiologyModels BiologicalCalcification PhysiologicGene expressionmedicineHumansViability assayCells CulturedOligonucleotide Array Sequence AnalysisOsteoblastsReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingMesenchymal stem cellIntracellular Signaling Peptides and ProteinsWnt signaling pathwayCell DifferentiationOsteoblastAlkaline PhosphataseCell biologyGene expression profilingmedicine.anatomical_structureFractures UnunitedBone
researchProduct

Predicted Indirectly reCognizable HLA epitopes (PIRCHE) are associated with poorer outcome after single mismatch unrelated donor stem cell transplant…

2019

There is no established standard for selection of mismatched unrelated donors. Indirect recognition of HLA mismatches can be predicted using the model of “Predicted Indirectly ReCognizable HLA Epitopes” (PIRCHE). We performed a multicenter retrospective study evaluating the impact PIRCHE on outcome after allogeneic stem cell transplantation (allo-HSCT) from single mismatched (HLA 9/10 matched) unrelated donors. The study cohort included 424 adult recipients of HLA 9/10 matched unrelated donor transplants (9/10 MUD), treated for AML or MDS at 6 transplant centers across Germany. Detection of PIRCHE was associated with lower overall survival (OS) (47 vs. 57%, <i>p</i> = 0.04), hig…

Oncologymedicine.medical_specialtyMultivariate analysisbusiness.industryIncidence (epidemiology)Retrospective cohort studyHematologyHuman leukocyte antigen030204 cardiovascular system & hematologyTransplantation03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureInternal medicineCohortmedicineImmunology and AllergyCumulative incidenceBone marrowbusiness030215 immunologyResearch Article
researchProduct

469: Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunos…

2007

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentUrologyRenal functionImmunosuppressionRegimenMulticenter trialSirolimusmedicineSurgeryCardiology and Cardiovascular Medicinebusinessmedicine.drugThe Journal of Heart and Lung Transplantation
researchProduct

The Large Observatory for X-ray Timing (LOFT)

2012

High-time-resolution X-ray observations of compact objects provide direct access to strong-field gravity, to the equation of state of ultra-dense matter and to black hole masses and spins. A 10 m^2-class instrument in combination with good spectral resolution is required to exploit the relevant diagnostics and answer two of the fundamental questions of the European Space Agency (ESA) Cosmic Vision Theme "Matter under extreme conditions", namely: does matter orbiting close to the event horizon follow the predictions of general relativity? What is the equation of state of matter in neutron stars? The Large Observatory For X-ray Timing (LOFT), selected by ESA as one of the four Cosmic Vision M…

Event horizonX-ray timingMission7. Clean energy01 natural sciencesneutron starsT175 Industrial research. Research and developmentBINARIESSettore FIS/05 - Astronomia E AstrofisicaALICESILICON DRIFT DETECTORObservatoryEQUATIONneutron star010303 astronomy & astrophysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Physics[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Astrophysics::Instrumentation and Methods for AstrophysicsMissions X-ray timing compact objects black holes neutron starscompact objectsAstrophysics - Instrumentation and Methods for AstrophysicsAstrophysics - High Energy Astrophysical PhenomenaPROPORTIONAL COUNTER[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Active galactic nucleusCosmic VisionX-ray astronomy; high time variabilityAstrophysics::High Energy Astrophysical Phenomenablack holes; compact objects; Missions; neutron stars; X-ray timing;FOS: Physical sciencesMissionsX-ray astronomy0103 physical sciencesOSCILLATIONSInstrumentation and Methods for Astrophysics (astro-ph.IM)Supermassive black holehigh time variability010308 nuclear & particles physicsAstronomyCONSTRAINTSAstronomy and Astrophysicsblack holesGalaxyBlack holeNeutron starSpace and Planetary ScienceQB460-466 AstrophysicsDISCOVERYBLACK-HOLESUPERAGILE
researchProduct

Supplementary Material for: Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) Are Associated with Poorer Outcome after Single Mismatch Unrelate…

2019

There is no established standard for selection of mismatched unrelated donors. Indirect recognition of HLA mismatches can be predicted using the model of “Predicted Indirectly ReCognizable HLA Epitopes” (PIRCHE). We performed a multicenter retrospective study evaluating the impact PIRCHE on outcome after allogeneic stem cell transplantation (allo-HSCT) from single mismatched (HLA 9/10 matched) unrelated donors. The study cohort included 424 adult recipients of HLA 9/10 matched unrelated donor transplants (9/10 MUD), treated for AML or MDS at 6 transplant centers across Germany. Detection of PIRCHE was associated with lower overall survival (OS) (47 vs. 57%, p = 0.04), higher non-relapse mor…

researchProduct